Martin Auster
Stock Analyst at Raymond James
(4.56)
# 1,004
Out of 4,685 analysts
211
Total ratings
51.3%
Success rate
16.1%
Average return
Main Sectors:
Stocks Rated by Martin Auster
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DYN Dyne Therapeutics | Maintained: Buy | $40 | $26.09 | +53.32% | 5 | Aug 25, 2026 | |
| STTK Shattuck Labs | Initiated Coverage: Buy | $18 | $7.65 | +135.29% | 1 | Aug 24, 2026 | |
| SEPN Septerna | Rated: Buy | $53 → $49 | $40.47 | +21.08% | 3 | Aug 11, 2026 | |
| ALNY Alnylam Pharmaceuticals | Maintained: Buy | $468 → $420 | $236.56 | +77.54% | 5 | Jul 31, 2026 | |
| PHAT Phathom Pharmaceuticals | Maintained: Buy | $28 → $21 | $8.94 | +134.90% | 2 | Jul 31, 2026 | |
| IBIO iBio, Inc. | Initiated Coverage: Buy | $5 | $1.40 | +257.14% | 1 | Jun 8, 2026 | |
| EWTX Edgewise Therapeutics | Reiterated: Buy | $46 → $66 | $44.19 | +49.36% | 4 | Jun 1, 2026 | |
| EQ Equillium | Maintained: Buy | $6 → $7 | $2.45 | +185.71% | 2 | May 28, 2026 | |
| TECX Tectonic Therapeutic | Maintained: Buy | $76 → $81 | $36.70 | +120.71% | 2 | May 26, 2026 | |
| BBIO BridgeBio Pharma | Downgraded: Hold | n/a | $78.68 | - | 4 | May 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $80 | $93.62 | -14.54% | 1 | Apr 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $53 → $60 | $59.26 | +1.25% | 5 | Mar 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $48 → $56 | $28.60 | +95.80% | 2 | Mar 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 | $13.48 | +196.74% | 2 | Jan 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $21 → $26 | $5.16 | +403.88% | 4 | Jan 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $108 → $117 | $82.55 | +41.73% | 4 | Jan 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $271 | $249.36 | +8.68% | 1 | Oct 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $77.90 | n/a | 1 | Jul 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $26 → $6 | $63.30 | n/a | 3 | Nov 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $102 → $100 | $65.29 | n/a | 14 | Oct 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $26 | $3.85 | n/a | 1 | Mar 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $7 → $8 | $10.13 | n/a | 4 | Mar 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $29 → $12 | $30.60 | n/a | 2 | Mar 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $49 → $58 | $32.59 | n/a | 6 | Mar 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $156 → $72 | $21.59 | n/a | 23 | Mar 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $169 → $196 | $527.91 | n/a | 17 | Feb 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $62 → $98 | $2.05 | n/a | 5 | Feb 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $64 → $99 | $26.26 | n/a | 15 | Jan 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 → $60 | $121.39 | n/a | 17 | Jan 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $53 → $54 | $71.81 | n/a | 12 | Jan 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $76 → $78 | $49.56 | n/a | 5 | Nov 20, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $11 → $12 | $4.24 | n/a | 9 | Nov 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $21 → $24 | $13.11 | n/a | 4 | Nov 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $27 → $43 | $13.18 | n/a | 4 | Oct 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $535.00 | n/a | 1 | Sep 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $14 | $32.50 | n/a | 4 | Sep 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $5 | $3.99 | n/a | 4 | Aug 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $16 | $57.29 | n/a | 8 | Jul 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $16 → $4 | $0.0001 | n/a | 3 | Nov 7, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $17 | $0.2179 | n/a | 1 | Jan 18, 2018 |
Dyne Therapeutics
Aug 25, 2026
Maintained: Buy
Price Target: $40
Current: $26.09
Upside: +53.32%
Shattuck Labs
Aug 24, 2026
Initiated Coverage: Buy
Price Target: $18
Current: $7.65
Upside: +135.29%
Septerna
Aug 11, 2026
Rated: Buy
Price Target: $53 → $49
Current: $40.47
Upside: +21.08%
Alnylam Pharmaceuticals
Jul 31, 2026
Maintained: Buy
Price Target: $468 → $420
Current: $236.56
Upside: +77.54%
Phathom Pharmaceuticals
Jul 31, 2026
Maintained: Buy
Price Target: $28 → $21
Current: $8.94
Upside: +134.90%
iBio, Inc.
Jun 8, 2026
Initiated Coverage: Buy
Price Target: $5
Current: $1.40
Upside: +257.14%
Edgewise Therapeutics
Jun 1, 2026
Reiterated: Buy
Price Target: $46 → $66
Current: $44.19
Upside: +49.36%
Equillium
May 28, 2026
Maintained: Buy
Price Target: $6 → $7
Current: $2.45
Upside: +185.71%
Tectonic Therapeutic
May 26, 2026
Maintained: Buy
Price Target: $76 → $81
Current: $36.70
Upside: +120.71%
BridgeBio Pharma
May 26, 2026
Downgraded: Hold
Price Target: n/a
Current: $78.68
Upside: -
Apr 10, 2026
Initiated Coverage: Buy
Price Target: $80
Current: $93.62
Upside: -14.54%
Mar 30, 2026
Reiterated: Buy
Price Target: $53 → $60
Current: $59.26
Upside: +1.25%
Mar 25, 2026
Reiterated: Buy
Price Target: $48 → $56
Current: $28.60
Upside: +95.80%
Jan 26, 2026
Reiterated: Buy
Price Target: $40
Current: $13.48
Upside: +196.74%
Jan 13, 2026
Reiterated: Buy
Price Target: $21 → $26
Current: $5.16
Upside: +403.88%
Jan 13, 2026
Reiterated: Buy
Price Target: $108 → $117
Current: $82.55
Upside: +41.73%
Oct 17, 2025
Initiated Coverage: Buy
Price Target: $271
Current: $249.36
Upside: +8.68%
Jul 30, 2025
Downgraded: Hold
Price Target: n/a
Current: $77.90
Upside: n/a
Nov 16, 2021
Maintained: Buy
Price Target: $26 → $6
Current: $63.30
Upside: n/a
Oct 28, 2021
Maintained: Buy
Price Target: $102 → $100
Current: $65.29
Upside: n/a
Mar 22, 2021
Initiated Coverage: Buy
Price Target: $26
Current: $3.85
Upside: n/a
Mar 16, 2021
Maintained: Hold
Price Target: $7 → $8
Current: $10.13
Upside: n/a
Mar 16, 2021
Maintained: Buy
Price Target: $29 → $12
Current: $30.60
Upside: n/a
Mar 10, 2021
Maintained: Buy
Price Target: $49 → $58
Current: $32.59
Upside: n/a
Mar 2, 2021
Maintained: Hold
Price Target: $156 → $72
Current: $21.59
Upside: n/a
Feb 22, 2021
Maintained: Buy
Price Target: $169 → $196
Current: $527.91
Upside: n/a
Feb 11, 2021
Maintained: Buy
Price Target: $62 → $98
Current: $2.05
Upside: n/a
Jan 25, 2021
Maintained: Hold
Price Target: $64 → $99
Current: $26.26
Upside: n/a
Jan 19, 2021
Reiterated: Buy
Price Target: $50 → $60
Current: $121.39
Upside: n/a
Jan 11, 2021
Maintained: Hold
Price Target: $53 → $54
Current: $71.81
Upside: n/a
Nov 20, 2020
Maintained: Buy
Price Target: $76 → $78
Current: $49.56
Upside: n/a
Nov 6, 2020
Maintained: Hold
Price Target: $11 → $12
Current: $4.24
Upside: n/a
Nov 5, 2020
Maintained: Hold
Price Target: $21 → $24
Current: $13.11
Upside: n/a
Oct 8, 2020
Maintained: Buy
Price Target: $27 → $43
Current: $13.18
Upside: n/a
Sep 23, 2020
Reiterated: Buy
Price Target: n/a
Current: $535.00
Upside: n/a
Sep 15, 2020
Maintained: Sell
Price Target: $14
Current: $32.50
Upside: n/a
Aug 3, 2020
Maintained: Hold
Price Target: $5
Current: $3.99
Upside: n/a
Jul 7, 2020
Maintained: Hold
Price Target: $16
Current: $57.29
Upside: n/a
Nov 7, 2019
Downgraded: Hold
Price Target: $16 → $4
Current: $0.0001
Upside: n/a
Jan 18, 2018
Initiated Coverage: Buy
Price Target: $17
Current: $0.2179
Upside: n/a